MedTrace Logo

Monitoring Movement Disorder Symptoms With a Mobile Medical App on Off-the-shelf Consumer Mobile Devices

NCT05680961 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-01-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether New Touch Digital (NTD) NeuroRPM software installed on wearable devices can objectively measure and track symptoms in patients with Parkinson's disease.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Monitoring Device

Monitoring Device

Sponsors & Collaborators

  • New Touch Digital Inc.

    collaborator INDUSTRY

  • Parkinson's & Movement Disorders Center of Maryland

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-19
Primary Completion
2020-06-01
Completion
2023-08-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05680961 on ClinicalTrials.gov